Evidence map›Paper›PMID 30893776›Full record

ReviewCancers2019

Contribution of Anoctamins to Cell Survival and Cell Death.

Karl Kunzelmann, Jiraporn Ousingsawat, Roberta Benedetto, Ines Cabrita, Rainer Schreiber

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TMEM16 proteins: CaInternational journal of molecular medicine · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. ANO10 Function in Health and Disease.Cerebellum (London, England) · 2023
    Review
  16. Article
  17. Inhibition of ANO1 byInternational journal of molecular sciences · 2023
    Article
  18. Hippo pathway in intestinal diseases: focusing on ferroptosis.Frontiers in cell and developmental biology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Karl KunzelmannInstitut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. Karl.kunzelmann@ur.de.ORCID 0000-0001-6222-4593
Jiraporn OusingsawatInstitut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. Jiraporn.Ousingsawat@vkl.uni-regensburg.de.
Roberta BenedettoInstitut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. Roberta.Benedetto@vkl.uni-regensburg.de.
Ines CabritaInstitut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. Ines.Cabrita@vkl.uni-regensburg.de.
Rainer SchreiberInstitut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. Rainer.Schreiber@vkl.uni-regensburg.de.
University of Regensburg · DE

Funding

Cystic Fibrosis Trust SRC013Deutsche Forschungsgemeinschaft KU756/14-1Mukoviszidose institute Ferroptosis in cystic fibrosisWilhelm Sander-Stiftung Anoctamins
6 · The paper itself

Abstract

Before anoctamins (TMEM16 proteins) were identified as a family of Ca

Indexed as

ANO1ANO6anoctaminapoptosisCa2+ signalingcancerinflammationproliferationTMEM16ATMEM16F

Identifiers

PMID30893776
PMCPMC6468699
OpenAlexW2921051103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.